Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer

This publication has 20 references indexed in Scilit:

• Sequential Addition of an Anthracycline-Based Regimen to Docetaxel as Neoadjuvant Chemotherapy in Patients with Operable Breast Cancer
  Clinical Breast Cancer, 2006
• High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer
  Breast Cancer Research and Treatment, 2005
• Pathological and Clinical Response of a Primary Chemotherapy Regimen Combining Vinorelbine, Epirubicin, and Paclitaxel as Neoadjuvant Treatment in Patients with Operable Breast Cancer
  The Oncologist, 2005
• Tumor Parameters, Clinical and Pathological Responses, Medical Management, and Survival Through Time on 710 Operable Breast Cancers
  Medical Oncology, 2005
• Neoadjuvant chemotherapy for breast carcinoma
  Cancer, 2003
• Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate
  British Journal of Cancer, 2003
• Efficacy of a Primary Chemotherapy Regimen Combining Vinorelbine, Epirubicin, and Methotrexate (VEM) as Neoadjuvant Treatment in 89 Patients with Operable Breast Cancer
  The Oncologist, 2002
• Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
  Journal of Clinical Oncology, 1998
• Clinical and pathological response to primary chemotherapy in operable breast cancer
  European Journal of Cancer, 1997
• Neoadjuvant chemotherapy in 126 operable breast cancers
  European Journal of Cancer, 1992